Screen Reader Access



Notices

Walk-in-interview for engagement of Project Staff under different Projects against Advertisement No. 10/2023 New

Shortlisted Candidates for the Position Code 008, Project Associate-II against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 006, Project Associate-I against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 005, Project Associate-I against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 007, Project Associate-I against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 004, Project Associate-I against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 003, Project Associate-I against Advertisement No. 09/2023 New

Notice for the Post of Technical Officer, Post Code TA 03,TA 04,TA 05 and TA 06 against Advertisement No. 11/2020 New

Shortlisted Candidates for the Position Code 001, Scientific Administrative Assistant against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 002, Project Associate-I against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 019, Senior Project Associate against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 018, Research Associate(Project) against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 016, Project Associate-II against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 017, SRF (Project) against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 013 (Project Associate-I) against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 012, Project Associate-I against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 015, JRF (Project) against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 014, Project Associate-I against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 011, Project Associate-I against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 010, , Project Associate-I against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 009, Project Scientist-I against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 020, Project Associate-I against Advertisement No. 09/2023 New

Shortlisted Candidates for the Position Code 021, Project Associate-I against Advertisement No. 09/2023 New

Result of Walk-in-Interview held on 06th Nov., 2023 for the post of Consultant in CSIR-CDRI against Advt No. 08/2023 New

Corrigendum reg. result for the post of Hindi Officer (Post Code-02) against Advt no. 03/2023 New

List of rejected and screened in applicants for the post of Technical Assistant, post code TA 07 in the area of Life Sciences advertised vide Advt. No. 11/2020 New

Result for the post of Hindi Officer (Post Code-02) against Advt no. 03/2023 New

Selection Committee Meeting for the positions of Project Staff (Position Code 002) against Advt. No. 06/2023 New

Selection Committee Meeting for the positions of Project Staff (Position Code 005) against Advt. No. 06/2023 New

Advertisement for engagement of Consultant in CSIR-CDRI against Advt. No. 08/2023 New

Result of Project Staff for the position code 001, 003, 004, 006 and 007 against Advt. No. 06/2023 New

Result of written examination for the post of Hindi Officer vide Advt no. 03/2023 New

Final Answer Keys and disposal of representations regarding Answer Keys for the written exam for the post of Hindi Officer vide Advt. No. 03/2023 New

Result of Project Staff for the position code 008, 009, 010, 012 to 020 against Advt. No. 06/2023 New

Answer Keys for the post of Hindi Officer against the Advt. No. 03/2023. If any objection to any of the answer, the same should be brought to the notice through email on so.e1[AT]cdri.res.in latest by 10th October, 2023 (05:30 PM) New

Result of Graduate Apprentice Trainee New

Cancellation of position code 011 for Project Staff against Advt. No. 06/2023 New

|| AnnexureNew

Archive NoticesNew

List of PAC OrdersNew|| Archive TendersNew

Tender for Supply of Vacuum Concentrator New

GeM Bidding for Orbital Shaking Incubators New

GeM Bidding for Refrigerated Centrifuge For General And Research Purpose New

GeM Bidding for Research Syringe pump New

Tender for Supply of Single Punch Tablet Machine New

GeM Bidding for Rotary Evaporator New

EOI for Ultra high performance liquid chromatography-high resolution mass spectrometer with accessories New

Tender for Spare parts of FTIR Model No- Spectrum- II New

Tender for Stat Ease Design Expert V22 Academic Standalone-user New

Tender for Probe sonicator with cup-horn assembly New

Tender for Design, Engineering, Fabrication, Supply, Installation, Testing, Commissioning and Validation of Bio-Safety Laboratory Level-3/ABSL-3 in a Pre-fabricated Container Based System on a Turnkey basis New

Tender for Turnkey Design, Installation and Commissioning of CRTDH GMP Materials Store Room New

Tender for procurement of Spare Parts for Agilent UPLC 1290 Infinity II New

Tender for Rate Contract Of Supply Of High Purity Gases New

Tender for Supply of Small Animal Anesthesia System New

GeM bidding for CO2 Incubator New

GeM bidding for Refrigerated Centrifuge For General And Research Purpose New

GeM bidding for Ultrasonic Probe Sonicator New

Tender for Repair of Biosafety Cabinet New

online bidding for Housekeeping & Maintenance of Guest Houses and Providing of Catering Services New

Tender for Supply of Spare parts of UV Spectrometer New

GeM bidding for Rotary Evaporator New

Tender for Supply of Analytical HPLC New

Tender for supply of vacuum concentrator New

Tender for Procurement of Computer Software New

Tender for Repair of Eppendorf Centrifuge 5810R New

Tender for Procurement of Spare Parts for Simadzu Nexera X2 LC-30AD Model No.-LC30AD New

Tender for Procurement of BioRender- Acadmic 3 Year Lab Subscription New

Tender for Procurement of Computer Software New


Message from Director


CSIR – Central Drug Research Institute, Lucknow is one of the premier research institutes of India which were envisioned by the National leaders much before the independence of our nation to drive and lead the technological independence. Dedicated in the service of nation on 17 February 1951, as a constituent laboratory of Council of Scientific & Industrial Research, India, our Institute has evolved into a unique R&D organization possessing end-to-end expertise for fundamental chemical and biomedical research driven new drug discovery and development. Apart from the new drug development, the Institute is richly contributing to the advancement of our understanding of disease biology in the areas of national priorities, and set-off revolution of Indian pharma sector over the past 70 years.

Dr. Radha Rangarajan

Director, CSIR-CDRI


Research Area

CDRI
CSIR-CDRI

Development of new drugs/drug combinations as therapeutic interventions for malaria, leishmaniasis and filariasis

Development of new drugs/drug combinations as therapeutic intervention for malaria, leishmanial and filariasis


Identification of unique targets and pathways for future interventions


Investigations on parasite biology and host-parasite interactions.

cdri
CSIR-CDRI

Development of novel agents for fracture healing and management of osteoporosis through modern drug design..

Development of novel agents for fracture healing and management of osteoporosis through modern drug design, scientific validation of traditional remedies and generation of new knowledge

CDRI
cdri

The World Health Organization has defined Antimicrobial resistance as the ability of a microorganism to stop an antimicrobial from working against it..

The World Health Organization(WHO) has defined Antimicrobial resistance (AMR) as the ability of a microorganism to stop an antimicrobial from working against it. As a result, standard treatments become ineffective, infections persist and may spread to others. It has further stated “AMR is of particular concern in developing nations, including India, where the burden of infectious disease is high and healthcare spending is low. The country has among the highest bacterial disease burden in the world. Antibiotics, therefore, have a critical role in limiting morbidity and mortality in the country.

CDRI
CSIR-CDRI

Affordable drugs for lifestyle diseases (CVS,CNS and related disorders) to achieve the dream “SWASTH BHARAT”

As per the estimates in the WHO non communicable disease (NCD) Country Profile 2014, Cardio- vascular disease (CVD) is the leading cause of Deaths in India and accounts for 26% of all deaths. As per WHO more than 4% of Indian population (3rd in world after USA and China) is obese, which is the main reason of major CVDs. In 2008, WHO declared dementia/AD as a priority condition through the Mental Health Gap Action Programs


cdri
CSIR-CDRI

Development of novel therapeutic agents for CVS, CNS and related disorders, cancer, fertility regulation (male/female)..

Development of novel therapeutic agents for CVS, CNS and related disorders, cancer, fertility regulation (male/female) and management of endocrine disorders through modern drug design, scientific validation of traditional remedies

CDRI
cdri

Meiosis is the defining event of spermatogenesis. Spermatocytes undergo meiosis to give rise to round spermatids, which in turn ...

Meiosis is the defining event of spermatogenesis. Spermatocytes undergo meiosis to give rise to round spermatids, which in turn metamorphose to flagellated spermatozoa that mature in the epididymis. To characterize the dynamics of gene expression during these important stages of spermatogenesis, undertook transcriptome analysis in >90% pure pachytene spermatocytes and round spermatids, and pure mature sperm of rat by massive parallel deep sequencing.

CDRI
CSIR-CDRI

Discovery and Development of New Avenues for Cancer Therapy and Diagnosis Making Cancer Care Affordable in India

Discovery and Development of New Avenues for Cancer Therapy and Diagnosis Making Cancer Care Affordable in India

cdri
cdri

Pre-clinical and clinical development of drug substances and drug products for diseases of national importance..

Pre-clinical and clinical development of drug substances and drug products for diseases of national importance, international relevance and public health needs


Continued engagement with drug regulation and pharmaceutical policy making in India as well as internationally

Our Drugs

E-MAL Arteether

For cerebral malaria as a second line treatment for chloroquine resistant cases, licensed to Themis Chemicals Ltd., Mumbai in 1997.

Keen Mind Bacopa Extract

Keenmind is marketed through Soho Flordis International, Sydney, Australia and is available now in India.

Saheli Centchroman

First non steroidal female oral contraceptive Licensed to HLL Lifecare Ltd., in 1992 & being marketed as SAHELI.

Reunion Dalzbone

Success Story of Development of New Herbal Medication for Bone Health.


MoUs/Licenses

Facilities & Services

Events & Activities


Campus Life@ CDRI



Important Links

Style Switcher